Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism
Kevin Domanegg, Wolfgang H. Sommer, Marcus W. Meinhardt
Cells (2023) Vol. 12, Iss. 6, pp. 963-963
Open Access | Times Cited: 18

Showing 18 citing articles:

The ReCoDe addiction research consortium: Losing and regaining control over drug intake—Findings and future perspectives
Rainer Spanagel, Patrick Bach, Tobias Banaschewski, et al.
Addiction Biology (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 12
The intensity of the psychedelic experience is reliably associated with clinical improvements: a systematic review and meta-analysis
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106086-106086
Closed Access | Times Cited: 1
Design, Synthesis, Pharmacology, and In Silico Studies of (1S,2S,3S)-2-((S)-Amino(carboxy)methyl)-3-(carboxymethyl)cyclopropane-1-carboxylic Acid (LBG30300): A Picomolar Potency Subtype-Selective mGlu2 Receptor Agonist
Na Liu, Floriane Eshak, Fanny Malhaire, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1314-1326
Closed Access | Times Cited: 4
Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder
Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4
Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies
Fahd François Hilal, Jérôme Jeanblanc, Chloé Deschamps, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 5, pp. 525-561
Closed Access | Times Cited: 3
Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats
Jonathan Reinwald, Christian N. Schmitz, Ivan Skorodumov, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder
Mary G. Hornick, Ashley Stefanski
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Synthesis and pharmacological characterization of conformationally restricted 2-amino-Adipic acid analogs and carboxycyclopropyl glycines as selective metabotropic glutamate 2 receptor agonists
Markus Staudt, Na Liu, Fanny Malhaire, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116157-116157
Open Access | Times Cited: 1
Modifications épigénétiques dans l’addiction à l’alcool et perspectives thérapeutiques
Olivier Pierrefiche
Bulletin de l Académie Nationale de Médecine (2024) Vol. 208, Iss. 4, pp. 451-458
Closed Access | Times Cited: 1
Ayahuasca for the treatment of alcohol use disorder
E.A.V. Marinho, Yasmim A. Serra, Alexandre J. Oliveira-Lima, et al.
International review of neurobiology (2024), pp. 283-300
Closed Access | Times Cited: 1
Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder
Claire Miller, Phillip R. Zoladz
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 1, pp. 100026-100026
Closed Access | Times Cited: 1
Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases
Izabela Szpręgiel, Izabela Szpręgiel
Pharmacological Reports (2024) Vol. 76, Iss. 6, pp. 1297-1304
Open Access | Times Cited: 1
Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction
Bettina Habelt, Dzmitry Afanasenkau, Cindy Schwarz, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction
Bettina Habelt, Dzmitry Afanasenkau, Cindy Schwarz, et al.
Research Square (Research Square) (2024)
Open Access
Modifications épigénétiques dans l’addiction à l’alcool et perspectives thérapeutiques
Olivier Pierrefiche
Annales Pharmaceutiques Françaises (2024)
Closed Access
Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders
Tamara Valdez, Valbhi Patel, Nattaphone Senesombath, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1484-1484
Open Access
Psilocybe cubensis: potencial neuropsicofarmacéutico de la psilocibina y psilocina
Frank Barrientos-Alfaro, Valeria Herrera-Rojas, Michelle Montero-Quesada, et al.
Revista Tecnología en Marcha (2024)
Open Access
Narrative Review of Psilocybin, an Important Psychoactive Substance With Potential Peri-anesthetic Implications
George Tewfik, Adejuyigbe Adaralegbe, Sangel Gomez, et al.
Trends in Anaesthesia and Critical Care (2024), pp. 101514-101514
Closed Access
Page 1

Scroll to top